In 2023, Avanos Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Avanos Medical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Avanos Medical amounted to 14,457.82 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Avanos Medical decreased by 2.78%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of Avanos Medical were 1,786.73 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2018, Avanos Medical's Scope 1 emissions have increased by 892.63%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Avanos Medical's Scope 1 emissions increased by 10.88%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Avanos Medical reported Scope 2 greenhouse gas (GHG) emissions of 12,671.09 tCOâ‚‚e without specifying the calculation method.
Since 2018, Avanos Medical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 93.93%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Avanos Medical's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Avanos Medical 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2023, Avanos Medical reported its Scope 2 emissions using an unspecified methodology.